We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Optical Immunosensors Improve POC Diagnostics

By LabMedica International staff writers
Posted on 12 Feb 2009
Optical immunosensors are precise, fast, easy-to-use systems for point-of-care diagnostics in hospitals, physicians' practices, or in homecare.

Scientists have been working on the development of selective monoclonal antibodies (mAbs) for certain target structures and for use in immunosensors for some time. More...
They have now succeeded in developing mAbs for procalcitonin (PCT), a specific marker for microbial infections and sepsis. Determination of PCT concentrations in serum is of significance, both for the early diagnosis of microbial infections and for controlling antibiotic treatment.

Using surface plasmon resonance (SPR) technology, biomolecular interactions between analytes in solution and antibodies immobilized on the surface of the sensor can be detected quickly, with high sensitivity, and without the otherwise required labeling of reaction partners.

SPR-based immunosensors are of interest for the detection of ligands in biomedical applications, in food, or in the environment. Dr. M. F. Gouzy, from the Institute of Ecological Chemistry, Helmholtz Center Munich (Munich, Germany), and colleagues have succeeded in developing a reusable SPR-based immunosensor, which is described in the February 2009 issue of the journal Biosensors and Bioelectronics.

Newly developed procalcitonin (PCT) antibodies from the rat were used successfully in the enzyme-linked immunosorbant assay (ELISA) in testing human serum for PCT. Some of these mAbs were marked with fluorescent dye and are presently being integrated by scientific groups in Germany and Italy into new optical immunosensors.

Related Links:
Helmholtz Center



Gold Member
Hybrid Pipette
SWITCH
POC Helicobacter Pylori Test Kit
Hepy Urease Test
HBV DNA Test
GENERIC HBV VIRAL LOAD VER 2.0
Silver Member
PCR Plates
Diamond Shell PCR Plates
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: LiDia-SEQ aims to deliver near-patient NGS testing capabilities to hospitals, labs and clinics (Photo courtesy of DNAe)

World's First NGS-Based Diagnostic Platform Fully Automates Sample-To-Result Process Within Single Device

Rapid point-of-need diagnostics are of critical need, especially in the areas of infectious disease and cancer testing and monitoring. Now, a direct-from-specimen platform that performs genomic analysis... Read more

Hematology

view channel
Image: Residual leukemia cells may predict long-term survival in acute myeloid leukemia (Photo courtesy of Shutterstock)

MRD Tests Could Predict Survival in Leukemia Patients

Acute myeloid leukemia is an aggressive blood cancer that disrupts normal blood cell production and often relapses even after intensive treatment. Clinicians currently lack early, reliable markers to predict... Read more

Pathology

view channel
Image: The AI tool advances precision diagnostics by linking genetic mutations directly to disease types (Photo courtesy of Shutterstock)

AI Tool Simultaneously Identifies Genetic Mutations and Disease Type

Interpreting genetic test results remains a major challenge in modern medicine, particularly for rare and complex diseases. While existing tools can indicate whether a genetic mutation is harmful, they... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.